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Objective. To determine whether Medicare managed care penetration impacted the
diffusion of endoscopy services (sigmoidoscopy, colonoscopy) among the fee‐for‐ser-
vice (FFS)Medicare population during 2001–2006.
Methods. We model utilization rates for colonoscopy or sigmoidoscopy as impacted
by both market supply and demand factors. We use spatial regression to perform eco-
logical analysis of county‐area utilization rates over two time intervals (2001–2003,
2004–2006) following Medicare benefits expansion in 2001 to cover colonoscopy for
persons of average risk. We examine each technology in separate cross‐sectional
regressions estimated over early and later periods to assess differential effects on diffu-
sion over time. We discuss selection factors in managed care markets and how failure
to control perfectly for market selection might impact our managed care spillover esti-
mates.
Results. Areas with worse socioeconomic conditions have lower utilization rates,
especially for colonoscopy. Holding constant statistically the socioeconomic factors,
we find that managed care spillover effects onto FFS Medicare utilization rates are
negative for colonoscopy and positive for sigmoidoscopy. The spatial lag estimates are
conservative and interpreted as a lower bound on true effects. Our findings suggest
that managed care presence fostered persistence of the older technology during a time
when it was rapidly being replaced by the newer technology.
Key Words. Endoscopy utilization, spatial regression analysis, Medicare
population trends, managed care spillovers, cost-effectiveness
BACKGROUND
More than 100,000 new cases of colorectal cancer (CRC) were detected in
2010, andmore than 50,000 people died fromCRC. Survival rates are 90 per-
cent if diagnosed early, yet only 39 percent of CRC cases are diagnosed at an
early stage (ACS, 2010). Medicare has covered CRC screening since 1998,
but use has been low, as only about 50 percent of beneficiaries had received a
CRC test during 1998–2005 (Schenck et al. 2009). Similarly, as of 2005, only





half of adults older than age 50 had been screened in the past 10 years (Shap-
iro et al. 2008). CRC remains the second leading cause of cancer death in the
United States, and there is concern over the low compliance with screening
recommendations (Klabunde et al. 2008; Holden et al. 2010).
The most recent American Cancer Society (ACS) guidelines for CRC
screening recommend four procedures that can both detect and prevent CRC
(barium enema, sigmoidoscopy, colonoscopy, and CT colonography) (ACS,
2008). The American College of Gastroenterology and the Centers for Medi-
care & Medicaid Services (CMS) view colonoscopy as the “gold standard”
(Rex et al. 2009; Neugut and Lebwohl 2010; CMS 2011); however, the U.S.
Preventive Services Task Force does not (USPSTF, 2007). The USPSTF rec-
ommends that choice among methods should be customized to patients or
practice settings, becausenoneof thevarious testmodalities couldbe identified
as superior in cost‐effectiveness analysis, tests were not uniformly accessible
and posed various risks to patients, and tests were not uniformly acceptable to
all patients (Pignone et al. 2002a,b;USPSTF, 2002;Whitlock et al. 2008).
The USPSTF recommends CRC screening for people aged 50 or older
because they have higher prevalence of this disease, which can be prevented
through routine screening and more effectively treated following early detec-
tion. While CRC screening was lower than national guidelines, three nation-
ally representative studies found dramatic increases in endoscopy use over the
period 2000–2005 for both the age 50+ and age 65+ populations (Shih, Zhao,
and Elting 2006; Shapiro et al. 2008; Doubeni et al. 2010). Several factors that
likely contributed to the increase include the expansion ofMedicare coverage
in 2001 for screening colonoscopy in people of average risk (Cooper and Ko-
roukian 2004), media coverage of colonoscopy, and changes in physician and
patient preferences (Shapiro et al. 2008). Colonoscopy use increased steadily,
whereas sigmoidoscopy use declined during 1998–2005 (Shapiro et al. 2008),
which is consistent with ourMedicare population data used here (Figure 1).
Colonoscopy procedures are more complex and cost more to perform
than sigmoidoscopy procedures. Medicare reimbursement rates, which are
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cost‐based, were (in 2007 dollars) $650 for colonoscopy and $350 for sig-
moidoscopy (AHRQ, 2007). Private insurers pay more, and there are signifi-
cant profit margins on endoscopy services, especially in outpatient settings
(Luchtefeld and Kim 2006); thus, physician groups have formed to offer these
services in competition with hospital outpatient departments (Berenson,
Bodenheimer, and Pham 2006). Sigmoidoscopy was the incumbent endos-
copy procedure, whereby the provider inserts a thin, lighted tube into the rec-
tum to examine the lower third of the colon while the more recent
colonoscopy procedure involves a longer, flexible tube to examine the entire
colon. Most polyps and some cancers can be found and removed during
either procedure, although polyp removal involves additional training and
equipment and sigmoidoscopy providers may not be equipped to do so (ACS
Figure 1: Expansion of Colonoscopy and Contraction of Sigmoidoscopy
Procedure Utilization over Time among Fee-for-Service (FFS) Medicare Ben-
eficiaries, 2001--2006
Notes. The maps in the four panels of this figure display sigmoidoscopy use rates in the top row,
and colonoscopy use rates in the bottom row. Moving left to right, the early period is defined as
2001--2003 and the late period is 2004--2006. Rates are defined as the sum of utilization in the
3 years divided by the average Medicare FFS population in the 3 years. Utilization was defined
from extracts of 100 percent of Medicare claims files, 2001--2006. Use rate categories were
defined identically in early and late periods to reveal changes in prevalence of use over time.
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2008). Colonoscopy involves more intensive advance preparation on the part
of the patient (to cleanse the upper colon) and poses greater risk of perfora-
tion, because the tube goes beyond a sharp bend separating the lower and
upper colon, and also poses risks associated with the ingestion of dehydrating
laxatives and fasting for several days.
Colonoscopy is considered superior by some experts because precan-
cerous lesions in the upper colon cannot be detected and removed by sig-
moidoscopy (Loeve et al. 2000a,b; O'Leary et al. 2003; Brenner 2008; Rex
et al. 2009). However, the superior efficacy of colonoscopy versus sigmoidos-
copy has been questioned in recent studies (Baxter and Rabeneck 2010; Neu-
gut and Lebwohl 2010). The lack of a body of evidence regarding superior
comparative or cost‐effectiveness advantages for colonoscopy over sigmoid-
oscopy have escalated focus in the United States on whether the extra cost of
colonoscopy is worthwhile for improving population health, as the vast
majority are not in the high‐risk category (Neugut and Lebwohl 2010; Subra-
manian, Bobashev, andMorris 2010; Goodwin et al. 2011).
Given the lack of consensus among experts regarding which test is
“best” and the higher procedure costs, it is surprising that the diffusion of col-
onoscopy has been so rapid. Although reasons are not apparent, some have
conjectured that the expansion of Medicare reimbursement of colonoscopy
to cover average‐risk persons was intended to reduce access barriers to CRC
screening, and it was expected to reduce disparities among minorities and
whites (Shih, Zhao, and Elting 2006). At about this same time, Medicare was
promoting use of managed care plans and the promise of managed care to
improve disease management and preventive services utilization and to slow
escalating health care costs resulting from poor management and prevention
(Greenwald et al. 2004; Hurley and Retchin 2006; Pope et al. 2006). Man-
aged care plans can control costs by assessing the cost‐effectiveness of various
treatment options and disseminating information and guidelines regarding
the preferred protocols for preventive health services. During this period of
uncertainty regarding which cancer screening modality was best, managed
care plans had an opportunity to exert influence on their providers and con-
stituents.
In this paper, we assess empirically whether managed care prevalence
seemed to have had any influence over the diffusion of colonoscopy relative
to sigmoidoscopy among fee‐for‐service (FFS) Medicare beneficiaries follow-
ing Medicare coverage expansion in 2001. We focus on these two endoscopic
procedures, which are near‐perfect substitutes from a payments perspective.
That is, for average‐risk Medicare‐insured persons aged 65+ during this time
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period, based on screening recommendations and Medicare reimbursement
rates, payments over a 10‐year interval were about the same for colonoscopy
and sigmoidoscopy. Screening guidelines recommend annual home fecal
occult blood testing (FOBT) with sigmoidoscopy every 5 years, OR colonos-
copy every 10 years, for persons of average risk (ACS 2008), and two sigmoi-
doscopies in 10 years cost about the same as a single colonoscopy (AHRQ
2007).
In addition, beneficiaries were required to pay 20–25 percent of the
procedure costs out‐of‐pocket, during this period, with the higher rate for ser-
vices provided outside of hospitals (MLN, 2006). From the patient's perspec-
tive, out‐of‐pocket costs at the point of service are lower for sigmoidoscopy,
patient time costs per procedure are lower, and procedure risks are lower. So
while near‐perfect substitutes from a planning perspective, patients and their
providers would likely view colonoscopy as having higher out‐of‐pocket and
time costs, and greater risk, with perhaps greater efficacy to prevent cancer.
Managed Care Plans and Endoscopy Use
Spillover effects from managed care have been variously defined as changes
in practice patterns, costs, or the diffusion of new technology relative to what
might occur in markets with little managed care influence (Miller and Luft
1994; Baker 2003). Changes in practice patterns can spill over to people who
are not insured by themanaged care plans (such as our FFS Medicare popula-
tion), but who are seen by the physicians who are affected by the information
the plans disseminate. Also, Medicare beneficiaries may compare treatment
options with and be influenced by the care patterns received by their peers
who are in managed care plans. These behavioral spillovers among people
are not expected to be contained within county boundaries, generating spa-
tial spillovers across people in adjacent counties. In this way, managed care
plans can impact the way medicine is practiced in their markets, impacting
adherence to screening guidelines by market participants, whether or not they
are enrolled in managed care plans.
If endoscopic CRC screening is cost‐effective, one might expect that
managed care plans would encourage its utilization. However, there is very
little empirical evidence regarding CRC screening modalities among Medi-
care managed care (MMC) constituents, because MMC plans are not
required to collect or publish utilization data; the only existing study found
that MMC enrollees were more likely to use FOBT than endoscopy, as
compared to their peers in FFS Medicare (Schneider et al. 2008). There is
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some limited evidence regarding managed care spillover effects on the utiliza-
tion of endoscopy in FFS Medicare in 1999, where modest positive impacts
on various CRC screening modalities were found (Koroukian et al. 2005).
The major contribution of this paper is to assess whether MMC pene-
tration impacted the diffusion of endoscopy services among the FFS Medi-
care population during 2001–2006. Medicare policy expanded in 2001 to
cover the newer, more expensive procedure that had no strong evidence of
cost‐effectiveness advantages for persons of average risk. This topic is timely
to inform ongoing health care reform efforts aimed at improving preventive
care services utilization and ultimately slowing the growth in national health
care expenditures.
METHODS
In this cross‐sectional study design, the outcome measures are county‐level
utilization rates of two CRC screening modalities (sigmoidoscopy and colo-
noscopy) utilized by the FFS Medicare beneficiary population over two inter-
vals, 2001–2003 and 2004–2006, residing in all counties in the continental
United States. Two time periods allow for comparisons over time that can
inform us regarding diffusion of the newer relative to the older technology.
We assess ecological spillover effects from MMC directly, by including
MMCpenetration as an explanatory variable, along with other statistical con-
trol variables needed to reduce potential selection effects that might impact
theMMC spillovers estimate.
Selection Effects
Medicare Part B insurance to cover outpatient and preventive care is discre-
tionary, and in the past decade, many poorer elderly could not afford this
coverage. In an effort to encourage MMC plan enrollment by low‐income
seniors who lacked preventive care or management, CMS subsidized the
MMC plans during this period so that low‐income seniors could obtain Part
B benefits at no additional cost (Greenwald et al. 2004; Pope et al. 2006).
Wealthier individuals were required to give up their very popular MediGap
supplemental insurance plans if they elected to join MMC plans, so elderly
with lower socioeconomic status (SES) were more likely to join MMC
than wealthier individuals (AHIP, 2005; Atherly and Thorpe 2005).
Therefore, FFS Medicare covers the relatively wealthier beneficiaries in
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MMC‐penetrated markets, and since higher‐income beneficiaries have been
shown to prefer colonoscopy procedures relative to other CRC modalities
(Phillips et al. 2007), FFS utilization of colonoscopy would appear relatively
higher in MMC‐penetrated markets than in unpenetrated markets. These
income dynamics portend a selection bias on the spillover effect from MMC
onto FFS constituents, which is toward higher utilization of colonoscopy.
Because of these selection issues, it is important to control statistically for
aspects of elderly SES so that a reliable estimate of the MMC spillover effect
can be identified.
As noted by Baker (2003) in his seminal work on this topic, studying
managed care spillovers, defined broadly as impacts on the structure and
functioning of the health care system in highly penetrated markets, requires
careful empirical model design to eliminate potential selection bias. It is
important to include in cross‐sectional studies (such as this one) comprehen-
sive controls for all factors that may be associated with performance or entry
by managed care organizations in the health markets being studied, to avoid
omitted variables bias in the spillover parameter estimate that would be
induced by selection effects. We included a comprehensive set of variables
(described below) to allow interpreting the managed care penetration effect
as a spillover effect on the FFS utilization rate outcomes. To further reduce
endogeneity problems caused by potential selection bias in contemporane-
ous data, we lagged theMMC penetration rate 2 years.
To identify the full set of confounding factors that are needed to control
statistically for potential selection effects, we developed a conceptual model
of the ecological predictors of endoscopy utilization (the outcome), based on
economic factors. Both supply and demand factors determine endoscopy use
rates in small areas (Tangka et al. 2005). Adoption (purchase) of endoscopy
equipment and acquiring the necessary training to use it will depend on the
expected return on investment, which is a function of market conditions.
Observed utilization rates will depend on various factors:
1. market size (density), which affects pace of return on investment;
2. socioeconomic status, acculturation, and educational attainment of
the treatment population; and
3. health market conditions, such as
i. prevalence of managed care plans,
ii. prevalence of endoscopy providers and service diffusion (lack of
specialization) among them, and
iii. importance ofMedicare as a market demand segment.
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We expect that counties with greater poverty over the past decade, or
with lower elderly educational attainment or English language ability, would
be less viable and unattractive to investors, thus characterized by smaller sup-
ply of endoscopy, resulting in lower utilization rates. Demand (willingness)
and ability to pay out‐of‐pocket expenses is also expected to be lower among
poorer, less educated or informed individuals. As investment in sigmoidos-
copy is cheaper (both procedure costs and training requirements are lower),
and because costs to the patient are lower, then all else equal, sigmoidoscopy
use rates are expected to be higher than colonoscopy use rates in less viable
markets.
Managed care has been known to slow the adoption of newer technol-
ogy and favor treatments with greater cost‐effectiveness (Miller and Luft
1994; Baker 2003). In urban areas where managed care is more prevalent,
managed care plans can impact the diffusion of newer technology by directly
impacting the decision whether to invest in endoscopy equipment. Thus, we
might expect markets with higher managed care penetration to have lower
utilization of colonoscopy and higher utilization of sigmoidoscopy. Our focus
is therefore on testing the hypothesis that, in areas where MMC was more
prevalent, there were negative spillovers on colonoscopy and positive spill-
overs on sigmoidoscopy use rates.
DATA
The study population is the entire Medicare FFS population aged 65+ and
residing in the continental United States, each year during 2001–2006. Alaska
and islands are excluded because spatial continuity is a fundamental premise
of the spatial regression analysis that we employ. Study outcomes are county‐
area utilization rates for sigmoidoscopy or colonoscopy procedures. We
included all persons each year with traditional FFS Medicare coverage (both
Parts A and B coverage for at least 11 months of the year). We used extracts
of 100 percent of Medicare Part B/physician carrier files for all claims with
endoscopy procedure codes, and we calculated the number of beneficiaries
who had received any endoscopy service in the year, by county. We then
summed the counts of beneficiaries who had used any annual endoscopy
over 3 years (2001–2003, 2004–2006) and divided this sum by the average
FFS population size (from the 100 percent denominator file) over the 3 years.
Using only the physician carrier file, we avoided duplication that might have
been obtained from using in addition hospital or outpatient facility files,
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reasoning that physician claims would be filed for every procedure regardless
of the delivery location. Counting persons with “any endoscopy” in the year
(rather than actual number of procedures per person) also controlled for pos-
sible errors from duplication in claims or service use. We used annual data
beginning in 2001, the first year that both types of endoscopy were covered
by FFS Medicare, and for every year thereafter through 2006.We used 3‐year
rates because screening recommendations are defined for time intervals;
thus, annual rates would be sparse and noisy. Two sequential rates were used
to allow assessment of any diffusion effects over time.
In addition, we used 100 percent Medicare population demographic
information from the Medicare denominator file and other factors describing
local market conditions from the U.S. Census and the CMS Geographic
Service Area Files. Table 1 presents the descriptions and data sources for the
variables, and Table 2 presents their sample statistics. The ecological
variables reflect aggregate conditions in counties across the continental
United States.
To develop the explanatory variables describing demand (population)
factors, we used the 100 percent Medicare denominator files to construct area
proportions representing race or ethnicity, and sex. As there are no data
describing SES in the Medicare files, we used several census variables,
including population density, proportion of elderly with poor or no English
language ability, and proportion of elderly with a graduate or professional
degree. We used annual county data from 1990 to 2000 and 1995 to 2005 to
calculate average 10‐year poverty rate in each county, thus calibrated to the
early and late screening intervals in the analysis. The MMC penetration rate
was derived using the CMSGeographic Service Area File, defined as the pro-
portion of Medicare eligibles in the county that were enrolled in MMC plans.
Other statistical control variables reflecting health status included propor-
tions of the Medicare beneficiary population by age group; with end‐stage
renal disease; or who were disabled as their original reason for Medicare enti-
tlement.
All endoscopy providers in our 100 percent claims files were used to
define endoscopy provider specialization indices. We used the market share
of each unique provider of endoscopy services delivered to FFS Medicare
beneficiaries in the county, then summed and squared the market shares, cre-
ating a quasi‐Herfindahl index(we did not have information regarding which
providers practiced together in groups) of market concentration. A higher
index number reflects greater concentration of services among fewer provid-
ers, but we wanted the opposite measure, which effectively deals with the
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Table 1: Variables Used in Modeling: All Data Used in Modeling Are
Aggregated to Reflect Proportions in Counties, County‐Specific Indices,
Per‐Capita Densities, or County Averages
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missing data for counties with no service providers. We converted the
Herfindahl into a “dispersion” index, which reflects lack of specialization. We
took the reciprocal of the county‐specific Herfindahl series, then converted
this into an index by dividing the series by the maximum value for the series
Table 2: Sample Statistics for County‐Level Variables
Years
2001–2003 2004–2006
Variables Mean SD Mean SD
Sample Size 3,099 Counties 3,099 Counties
Outcome
Colonoscopy use rate 0.252 0.049 0.279 0.045
Sigmoidoscopy use rate 0.037 0.018 0.018 0.009
Age <65 (omitted reference group) 0.162 0.060 0.177 0.063
Age 65–74 0.449 0.037 0.441 0.039
Age 75–84 0.289 0.035 0.283 0.037
Age 85+ 0.100 0.024 0.099 0.025
Female 0.553 0.028 0.548 0.028
Asian 0.002 0.007 0.003 0.008
African American 0.073 0.127 0.074 0.128
Hispanic 0.010 0.034 0.009 0.031
Native American 0.007 0.038 0.009 0.048
Population density 239.3 1671.0 243.2 1686.2
Little or no English language ability, elderly
(age 65+)
0.143 0.147 0.143 0.147
Graduate or professional degree, elderly (age 65+) 0.044 0.028 0.044 0.028
Medicare importance in area 0.141 0.020 0.148 0.020
10‐Year average poverty rate 0.148 0.067 0.141 0.057
Index of nonspecialization of endoscopy providers 0.020 0.046 0.019 0.047
Medicaremanaged care (MMC) penetration 0.048 0.089 0.043 0.090
Table 1. Continued
Variable Name Variable Description Source
MMC
penetration
Proportion of beneficiaries inMMC
plans in 1998 and 2001(lagged to
reduce endogeneity)
CMSGeographic Service Area






Diffusion index defined from
unique endoscopy provider shares
of countymarkets, in 2001 and 2004
100%Medicare denominator
files, 2001–2006
Notes. *Included in analysis but excluded from reported statistics and results tables.
CMS, Centers for Medicare & Medicaid Services; FFS, fee‐for‐service; ESRD, end‐stage renal
disease;MMC,Medicaremanaged care.
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in that year. We then assigned “0” to areas with missing data (no providers);
thus, the index reflects diffusion of services provision among many separate
physicians. The larger the measure, the less specialized/more dispersed are
these services among available providers, and no dispersion (“0”) reflects no
providers.
STATISTICAL ANALYSIS
Spatial correlation across adjacent areas in public goods or preventive
health care services subject to resource constraints is fairly common
(Brueckner 1998, 2003; Brueckner and Saavedra 2001; Mobley et al.
2006). When people share information and resources across county bound-
aries, adjacent county outcomes will be spatially correlated. Ignoring these
misspecification problems is equivalent to falsely assuming that observa-
tions (county utilization rates) are statistically independent, which is a
standard assumption under ordinary least squares (OLS) regression. This
can lead to either efficiency bias, parameter bias, or both (Anselin 1988,
2006; Anselin, Le Gallo, and Jayet 2008). Recent papers have shown that
ignoring spatial spillovers can yield highly inflated estimates of the mar-
ginal impact of living in rural poverty on preventive care service utilization
by the elderly (Mobley et al. 2006) and misleading antitrust prescriptions
(Mobley, Frech, and Anselin 2009). As we show below, ignoring spatial
spillovers in this paper could result in inflated effect estimates for MMC
spillover effects.
Because the decision regarding whether to establish endoscopy ser-
vices in a county may be affected by prevalence of these services in adjacent
counties, we expect there will be spatially correlated errors in the models.
We used the residuals from OLS regression as diagnostics to test for spatial
correlation and then determine the form of spatial regression that best fits the
data, using a Lagrange Multiplier test (Anselin 1988; Mobley 2003). We
found significant spatial correlation in the OLS regression residuals and
determined that the spatial lag model is a better fit to these data than the spa-
tial error model. We used the spatial lag model specification1 to perform
small area, ecological analysis of the predictors of sigmoidoscopy and colo-
noscopy use rates in U.S. counties over an early (2001–2003) and later
(2004–2006) time period.
We incorporate the lag model within a seemingly unrelated regression
(SUR) framework (Anselin 1988). The SUR framework allows us to
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estimate separate regression equations for each service type (colonoscopy or
sigmoidoscopy) at each time period, pooling the two equations over time
for each service type. The SUR approach correlates the error terms for
observations (counties) across time (the two equations), and we find that this
significantly improves the efficiency of the effect estimates (Zellner 1962).
The spatial SUR model allows for spatially correlated error terms within
each equation and across equations, with separate parameter estimates for
each time period. To assess diffusion effects, we performed parameter‐spe-
cific Wald tests (Anselin 1988, 1990) to test for the stability of parameters
across time.
RESULTS
We present findings from the spatial SUR models in Table 3, and we high-
light the parameter estimates that are statistically significant at the 5 percent
level or better in bold font. Table 4 contains misspecified OLS results for
comparison. Asterisks indicate parameter estimates that changed signifi-
cantly over time, based onWald tests.
The spatial lag parameter estimate is large and positive (ranging from
0.481 to 0.574 across models) and statistically significant. A positive spatial
lag effect indicates that competition for scarce resources and information
spillovers cross county boundaries; thus, adjacent counties are impacted by
the same market forces. This spatial correlation across adjacent counties
means that observations are not independently distributed, and an OLS
model is misspecified. In error processes with spatial lag, this results in multi-
plier bias on the OLS estimates (see bottom of Table 3 for size of multiplier
bias), and in these data OLS parameter estimates are inflated to about double
the actual magnitude of effect via the spatial multiplier bias (Mobley, Frech,
and Anselin 2009). This multiplier bias can be demonstrated by comparing
the misspecified OLS results in Table 4 to the lag model results in Table 3.
Thus, using OLS estimates for policy prescriptions, one would profess larger
spillover effects at work than are actually present.
Regarding our main hypothesis, we find that areas with higher MMC
penetration have significantly higher sigmoidoscopy use and significantly
lower colonoscopy use. The MMC spillover estimate for colonoscopy in the
early period is 0.029 (versus 0.051 from the misspecified OLS model),
while the estimate for sigmoidoscopy is 0.06 (versus 0.017 from the OLS
model).
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The MMC penetration variable standard deviation is twice the magni-
tude of the mean (see Table 2), so large changes (larger than 10 percent) are
actually consistent with our data. If we interpret the lag estimates in terms of
elasticities, we find that a 10 percent increase inMMCpenetration in the early
period is associated with about a 6 percent decrease in the colonoscopy use
rate, and about an 8 percent increase in the sigmoidoscopy use rate. In the later
period, the colonoscopy elasticity effect is a 3 percent decrease, while the sig-
moidoscopy effect is a 12 percent increase. For both screening modalities, the
changes over time in the MMC spillover effect estimates are not statistically sig-
nificant, based on theWald tests. However, for both, theMMC spillover effect
is statistically significant and large enough to be economicallymeaningful.
The various statistical controls for market factors generally have signifi-
cant parameter estimates and are of the expected sign. In particular, markets
with higher 10‐year poverty rates show slightly lower sigmoidoscopy use and
much lower colonoscopy use. This suggests that sigmoidoscopy can survive
in less viable markets as compared to colonoscopy, and increasingly so over
time.
We recognize that we may not have been able to control completely for
socioeconomic factors responsible for selection bias. In this case, our estimate
of the MMC spillover effect on colonoscopy use is conservative and may be
construed as a lower bound on the true effect. To see this, because selection
effects related to the MMC spillovers tend to increases utilization of colonos-
copy, and the actual spillover effect is negative, then the bias is toward the
null, resulting in a smaller negative effect estimate than may actually be the
case.
To test whether our selection theory is valid, we added an additional
socioeconomic control variable (a measure of dual eligibility among the FFS
elderly) as a robustness check. Although the dual eligibility measure is not a
reliable indicator of all FFS elderly in poverty or enrolled in Medicaid, it is
correlated at >80 percent (simple Pearson) with area 10‐year poverty, and it
more specifically represents the FFS population. These results (available
from the authors upon request) confirm our selection theory. Adding dual
eligibility for the FFS beneficiaries to the model as an additional control var-
iable (which was highly significant) resulted in a slightly larger magnitude,
negative spillover effect for colonoscopy. However, in terms of the elastici-
ties associated with a 10 percent increase in MMC penetration, the effects
were not noticeably different. For the sigmoidoscopy model, there was no
significant dual eligibility effect and the spillover estimates were not
affected.
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A more direct approach to deal with selection bias would be the
use of an instrumental variables (IV) estimator. We could not find very
reliable instruments, but exploratory work with IV models suggested
potential selection bias from omitted variables was much smaller than the
bias from ignoring spatial lags. As it is not possible to control for both
spatial spillovers and selectivity using a single estimator, we opted for the
spatial estimator because the spatial multiplier bias appears to be larger
than any remaining selection bias. We can only reduce the selection bias
by lagging MMC penetration, not completely eliminate it. Remaining
selection bias probably leads to conservative estimates (underestimates) of
the magnitude of spillover effects from MMC penetration on endoscopy
use.
DISCUSSION AND CONCLUSION
Evidence from the nationally representative National Health Interview Sur-
vey suggests that the number of endoscopy procedures performed on those
privately insured and those enrolled in Medicare was approximately the
same and that a similar proportion of each group used endoscopy for CRC
screening, with increasing utilization of colonoscopy relative to sigmoidos-
copy for both groups (Shapiro et al. 2008). It would be enlightening to study
the role of the spread of managed care on the diffusion of these two compet-
ing procedures for the entire insured population in the United States. How-
ever, no data are available to do that. We do have excellent data to study
this phenomenon in the Medicare population, which is the focus of this
paper.
We use county‐level ecological analysis with spatial regression to assess
whether MMC penetration had any impact on the rate of use of colonoscopy
or sigmoidoscopy among the FFS Medicare‐insured population. Any impact
from MMC on FFS Medicare would be interpreted as a spillover effect, act-
ing through managed care's influence on both providers and constituents in
their markets.
As MMC plans are all provided by private insurance companies that
also offer plans for other consumers in the same markets (Pope et al. 2006),
and because trends in endoscopy use among Medicare and private popula-
tions have been similar, the Medicare market may provide useful, albeit indi-
rect evidence about the managed care impact across the entire U.S. insurance
market. Conversely, what we observe for the Medicare market may reflect
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larger forces at work than simply the influence of MMC plans on Medicare
constituents’ behavior.
This is the first study to examine managed care's impact on the relative
diffusion of these two competing endoscopy technologies. We find evidence
that markets with worse socioeconomic conditions are less viable for colonos-
copy than sigmoidoscopy. Holding constant statistically the confounding
influences of socioeconomic factors, this study provides the first evidence to
date regarding the role that MMC plans have played in the diffusion of colo-
noscopy following benefits expansion to cover it in 2001.
We find that counties with greater MMC penetration had lower colo-
noscopy use, but higher sigmoidoscopy use, and that these spillover effects
did not change significantly over time. Counties with 10 percent higher
MMC penetration than average saw about 3–6 percent lower colonoscopy
rates and 8–12 percent higher sigmoidoscopy rates over 2001–2006. Thus,
MMC plans may have played an important role in sustaining the practice of
sigmoidoscopy and slowing down the diffusion of colonoscopy.
During the period we study, colonoscopy technology transitioned from
being a “gold standard” promoted by the American College of Gastroenter-
ology (Rex et al. 2009) to one increasingly questioned by the mounting evi-
dence base, especially in the face of considerable risks posed to older
persons from the procedure itself (Whitlock et al. 2008). Now that rising bud-
get deficits are looming, economists are questioning the cost‐effectiveness of
colonoscopy and providing more evidence against it (Subramanian, Boba-
shev, and Morris 2010; Goodwin et al. 2011). Perhaps in this time of
increased cost‐consciousness, managed care practices will return to positions
of influence and imbue more constraint on the diffusion of cost‐increasing
technologies.
ACKNOWLEDGMENTS
Joint Acknowledgment/Disclosure Statement: This work was supported by a
National Cancer Institute grant (1R01CA126858). The content is solely the
responsibility of the authors and does not necessarily represent the official
views of RTI International, Arizona State University, The University of Cali-
fornia at Santa Barbara, the University of North Carolina at Chapel Hill, the
National Cancer Institute, or the National Institutes of Health.
Disclosures: None.
Disclaimers: None.
1922 HSR: Health Services Research 46:6, Part I (December 2011)
NOTE
1. The spatial lag model includes the average of neighboring values of the dependent
variable, treated as an endogenous explanatory variable:
Y ¼ qWY þ X bþ e
where WY is the spatial autoregressive and X is the regressive component of the
model, ρ is the spatial autoregressive “lag” parameter, and e is the vector of regres-
sion disturbances (i.i.d). Y is the vector of observations on the dependent variable, X
is the matrix of exogenous variables, and W is an N 9 N matrix (by convention, W
is row‐standardized and does not define an observation as its own neighbor). The
termWY is the spatial lag of Y.
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